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ABSTRACT 
 
 Small heat shock proteins (sHSPs) are a 
conserved group of molecular chaperones with 
important roles in cellular proteostasis. Although 
sHSPs are characterized by their small monomeric 
weight, they typically assemble into large 
polydisperse oligomers that vary in both size and 
shape but are principally composed of dimeric 
building blocks. These assemblies can comprise 
different sHSP orthologues, creating additional 
complexity that may affect chaperone activity. 
However, the structural and functional properties 
of such heterooligomers are poorly understood. 
We became interested in heterooligomer formation 
between human heat shock protein family B 
(small) member 1 (HSPB1) and HSPB6, which are 
both highly expressed in skeletal muscle. When 
mixed in vitro, these two sHSPs form a 
polydisperse oligomer array composed solely of 
heterodimers, suggesting preferential association 
that is determined at the monomer level. 
Previously, we have shown that the sHSP N-
terminal domains (NTDs), which have a high 
degree of intrinsic disorder, are essential for the 
biased formation. Here we employed iterative 
deletion mapping to elucidate how the NTD of 
HSPB6 influences its preferential association with 
HSPB1 and show that this region has multiple 
roles in this process. First, the highly conserved 
motif RLFDQxFG is necessary for subunit 
exchange among oligomers. Second, a site 
approximately 20 residues downstream of this 
motif determines the size of the resultant 
heterooligomers. Third, a region unique to HSPB6 
dictates the preferential formation of heterodimers. 
In conclusion, the disordered NTD of HSPB6 
helps regulate the size and stability of 
heterooligomeric complexes, indicating that 
terminal sHSP regions define the assembly 
properties of these proteins.
 
 
 Heat shock proteins are an indispensable 
group of proteins in charge of maintaining cellular 
proteostasis. This protein superfamily ensures both 
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the correct folding of newly synthesized proteins 
and prevents unfolding and aggregation under 
stress conditions (1). Small heat shock proteins 
(sHSPs) are an important subfamily of this 
network and capture proteins in the early stages of 
unfolding, thereby preventing aberrant interactions 
leading to aggregation (2). sHSPs are capable of 
binding a wide variety of substrate proteins within 
the cell, and are considered a first line of defense 
of the protein quality control network (3±6). 
 Small heat shock proteins are notorious 
for assembling into large polydisperse complexes, 
comprised of up to 40 subunits for some members 
(7±9). These assemblies are formed from dimeric 
building blocks, where  the constituent monomeric 
subunits can freely exchange (10). Dimer 
association is mediated by the core structured 
UHJLRQ RI V+63V WKH Į-crystallin domain (ACD) 
(11±14). Crystal structures of the isolated ACD of 
a number of metazoan sHSPs show a 7-VWUDQGHGȕ-
sandwich that readily assembles into dimers via 
anti-parallel pairing RI WKH ȕ-strand (15±17). 
Within this kingdom higher order assembly into 
the larger oligomeric species, as well as regulation 
of subunit exchange of the component protomers, 
is controlled via the N- and C-terminal arms that 
flank the ACD (18). Other than the presence of a 
tripeptide IxI/V motif, termed the C-terminal 
anchoring module (19),  these domains are 
generally considered to be poorly conserved and 
are predicted to lack secondary structure making 
characterization of their role in assembly 
particularly challenging.   
 This multifaceted structural association 
and dynamics is further complicated by 
heterooligomerization, in which two or more 
orthologous sHSPs co-assemble into the typical 
high molecular weight complexes (20±24). This 
phenomenon has been described for bacterial, 
plant and metazoan sHSPs (21, 25, 26). In 
humans, numerous members of the sHSP family 
have been shown to interact with each other (23), 
the most well-known complex beLQJ OHQV Į-
crystallin, which is composed RI Į$- DQG Į%-
crystallin in a 3:1 monomer ratio (27, 28). 
Although present in this ratio in most vertebrate 
lenses, when mixed in vitro they form a hetero-
oligomer containing subunits consistent with the 
proportion used (29, 30). TKH Į-crystallin 
heterocomplex therefore shows a ratio of the 
component sHSPs that likely reflects their relative 
expression levels. At the same time, there are 
number of human orthologues that, when mixed 
together in various ratios, form heterooligomers 
with a specific subunit stoichiometry (20, 31).  
 In this study we focus on the biologically 
relevant complex formed between HSPB1 and 
HSPB6, two sHSPs that coassemble in muscle 
tissue where they are both highly expressed (32, 
33). Previous studies of the human HSPB1 and 
HSPB6 heterooligomers have shown that they 
form highly polydisperse complexes containing an 
equimolar amount of each sHSP (31, 34). 
Assuming both sHSPs can freely exchange 
subunits, random protomer turnover would be 
expected to result in oligomers containing both 
homo and heterodimers. Recently, using native 
mass spectrometry, we have observed that 
although both sHSPs alone can exchange subunits 
in such a stochastic fashion, the heterooligomeric 
complex is composed solely of heterodimers (35). 
This result, in good agreement with earlier residue 
specific cross-linking studies (21), supports a 
heterooligomer model where HSPB1 and HSPB6 
preferentially associate at the core dimer level. 
Curiously this preferred association, which is 
mediated by the ACD, requires the presence of the 
highly flexible NTDs (35). This latter region of 
human HSPB1 is 90 residues long and has low 
sequence homology with the 72 residue NTD of 
HSPB6, with the most prominent exception being 
a conserved RLFDQxFG motif close to the center 
of this domain in the two proteins. Due to these 
distinct differences, how this disordered region 
dictates the association properties of the structured 
ACD is not understood.  
Here we have used a library of deletion 
constructs, previously employed to investigate the 
role of the NTD of HSPB6 in chaperoning (36), to 
identify the N-terminal residues in this sHSP that 
dictate heterooligomerization. The effect of these 
deletions, as well additional point mutants, on the 
subunit exchange behavior with HSPB1 were 
analyzed by an array of techniques including size 
exclusion chromatography, mass spectrometry 
(MS) and disulfide mediated cross-linking studies. 
The results point to a complex mechanism where 
different sequences within the NTD of HSPB6 
influence the initial association of the two sHSPs, 
the size of the resultant heterooligomeric 
assemblies, and the preferential heterodimerisation 
with HSPB1.  
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RESULTS 
 
Deletion mapping of the HSPB6 NTD defines 
regions involved in heterooligomersation 
N-terminal deletion constructs of human 
HSPB6, used previously to identify substrate 
binding sites of this sHSP (36), were employed to 
map the residues within the NTD that are required 
for the preferential association with HSPB1. 
Previous characterization of these HSPB6 
constructs showed that they were all dimeric in 
solution, similar to the wild type (WT) protein. 
This thus permits an investigation of the possible 
effect of truncation on the size distribution of 
formed heterooligomers without fear of 
interference of aberrant homooligomers of the 
deletion constructs. 
 The equimolar mixture of WT HSPB1 and 
HSPB6 prepared at 37oC yielded a broad elution 
profile on analytical SEC, composed of two peaks 
with maxima corresponding to a molecular weight 
of 508 and 160 kDa, in line with previous studies 
(35). The corresponding eluted fractions contained 
equimolar amounts of both sHSPs when analysed 
by SDS-PAGE (Fig. 1). All seven HSPB6 deletion 
constructs were capable of forming a 
heterooligomer with HSPB1, albeit with differing 
elution profiles for some (Fig. 1). Most notably, 
deletion of residues 51-60 led to the predominant 
formation of the smaller heterooligomeric species 
at the expense of the larger complex, despite these 
entities containing equal amounts of both sHSPs in 
SDS-PAGE analysis of the fractions. Another 
striking difference was observed with constructs 
that lack residues 21-30 and 31-40. In both cases 
not all of the HSPB6 construct was incorporated 
into the complex, as evidenced by a dominance of 
HSPB1 in the SDS-PAGE analysis of fractions of 
the heterooligomer peak, as well as by a small 
remnant peak of the HSPB6 deletant alone in the 
SEC chromatogram (Fig. 1). 
 SEC-coupled SAXS experiments of the 
same mixtures showed a single elution peak, likely 
due to a lower resolving power of the Shodex 
column compared to the Superdex 200 column 
(Supplemental Fig. 1). The calculated average 
mass of the complex between both WT proteins 
corresponds to 360 kDa and has a Rg value of 51 Å 
at the elution peak maxima, with a range of 39.5 to 
52.4 Å (Table 1). This is smaller than the WT 
HSPB1 but larger than WT HSPB6, which have a 
Rg at the elution peak of 58 Å and 32 Å 
respectively. Combined these values are in 
agreement with the heterooligomer being a 
polydisperse mixture containing species whose 
size ranges vary between those of the component 
homooligomers  (Fig. 1, Supplemental Fig. 1).  
For the majority of complexes formed between the 
different HSPB6 deletions and HSPB1, the peak 
Rg value as well as the Rg range were similar to 
that of the WT complex. However, the deletion of 
residues 51-60 resulted in a clearly smaller species 
with a peak Rg of 41.6 Å. At the same time, the 
two truncations that did not form a complex with 
HSPB1 HIILFLHQWO\ ǻ- DQG ǻ-40) showed 
an increased peak Rg value of 57 Å as well as a 
wider range in Rg from 57 Å to 33 Å. This 
correlates well with the higher resolution SEC 
studies that showed the presence of both a larger 
species, containing predominantly HSPB1, as well 
the non-associated HSPB6 deletion dimeric 
species (Fig. 1). 
 To ascertain whether the heterooligomers 
formed between HSPB1 and the different HSPB6 
truncations were composed primarily of 
heterodimers, disulfide cross-linking was used. To 
this end, an additional double mutation 
C46S.E116C (denoted by an asterisk in subsequent 
construct names) was introduced in every HSPB6 
deletion construct. A single mutation E116C was 
introduced in ǻ-50 where the native cysteine is 
absent. E116 and the corresponding residue C137 
in HSPB1 residuHLQWKHȕVWUDQGRIWKH$&' are 
located near the two-fold axis of the APII  dimer 
interface (Fig. 2A, Supplemental Fig. 3A) (16, 18). 
This proximal position of the cysteines means that 
both WT HSPB1 and the HSPB6* mutant can be 
readily cross-linked across the dimer interface by 
oxidation (16). Likewise, disulfide cross-linking of 
the heated HSPB1/HSPB6* mixture yields a 
species with a mass between that of the HSPB1 
and HSPB6 cross-linked dimers when analyzed by 
non-reducing SDS-PAGE (Fig. 2B and C). 
Importantly introduction of the C46S.E116C 
double mutation results in wild type exchange 
behavior (21). In our hands the additionally 
mutated HSPB6 truncations all behaved like their 
non-mutant equivalent during purification (data 
not shown). 
The results of the disulfide cross-linking 
clearly show that all HSPB6 truncations except for 
ǻ-30* DQGǻ-40* are nearly fully engaged in 
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a heterodimeric complex with HSPB1, just like the 
full-length proteins (Fig. 2B). In contrast, the ǻ-
30* DQGǻ-40* constructs, when incubated with 
HSPB1, reveal three bands, corresponding to 
cross-linked HSPB1 homodimer, the heterodimer 
and the HSPB6* homodimers respectively. As 
assessed by densitometry of the stained gels, the 
molar ratio of these species was close to 1:0.5:1 
(corresponding to 20% heterodimer formation). 
This suggests that the deletion of these regions in 
HSPB6 hampers the heterodimer formation. To 
test whether WKHǻ-30DQGǻ-40* constructs 
were capable of forming a cross-dimer disulfide 
when alone, a control oxidation experiment was 
performed that demonstrated that they oxidized as 
readily as all other constructs under the conditions 
employed (Fig. 2C). To rule out the further 
possibility that WKH ǻ- DQG ǻ-40 deletions 
limited HSPB6 subunit exchange, native MS 
analysis of 15N-labeled sample mixed in a 1:1 ratio 
with non-labeled sample was performed. The MS 
spectra showed that in both cases subunit turnover 
was not limited, as a stochastic 1:2:1 ratio of non-
labeled, monolabeled and dilabeled dimers was 
observed (Supplemental Fig. 2). 
  In addition, native MS experiments with 
the preincubated 1:1 mixtures of HSPB1 and the 
various HSPB6 truncations were performed (Fig. 
3). Just like the WT protein, all HSPB6 truncations 
H[FHSW IRU ǻ- DQG ǻ-40, revealed almost 
exclusively the presence of hetero-dimers with 
HSPB1. The lack of detection of larger 
heterooligomeric species was previously observed, 
and likely due to both the low protein 
concentrations used and less efficient detection of 
the resulting high-m/z ions (35). Experiments 
involving the ǻ11-20, ǻ41-50 and ǻ51-60 
constructs additionally showed a small fraction of 
HSPB6 homodimers, and dissociated monomers, 
which could be due to a slight molar excess of the 
HSPB6 construct due to inaccuracies in 
concentration determination. Crucially for the 
ǻ- DQG ǻ-40 HSPB6 constructs no 
heterodimer was observed (HSPB1 is not visible 
in these spectra, as it occurs as larger oligomers ± 
mainly tetramer ± under these conditions). Thus 
both the cysteine cross-linking and the native MS 
experiments together suggest that the region found 
between residues 21 to 40 of HSPB6 is necessary 
for heterocomplex formation with HSPB1. 
 
Specific contributions of several regions within the 
HSPB6 NTD in heterocomplex assembly 
 
To investigate the regions that influence 
heterooligomerization in more detail, a series of 
HSPB6 constructs with shorter deletions were 
cloned and purified. First of all, we evaluated 
which amino acids in the region encompassing 
residues 51-60 are responsible for the formation of 
the larger heterooligomeric species (which are 
diminished upon deletion of this sequence, Fig. 1) 
by creating two 5aa deletion constructs. Analytical 
SEC analysis of HSPB1 preincubated with the 
HSPB6 ǻ-60 construct showed a profile exactly 
like that of the mixture of the WT sHSPs, whereas 
deletion of residues 51-55 biased the hetero-
oligomer profile to the smaller species (Fig. 4A). 
Residues within this latter region are found to be 
somewhat conserved in other HSPB6 homologues 
known to interact with this sHSP, the core of 
which is a tripeptide sequence where the terminal 
residues are typically proline and tyrosine (Fig. 
4B) (26). 
 Next, we addressed the contribution of the 
HSPB6 region encompassing residues 21-40. The 
results from SEC and disulfide cross-linking on 
the four 5aa HSPB6 deletions (Fig. 5) provided 
more detail on the involvement of this region in 
heteroROLJRPHU IRUPDWLRQ 7KH ǻ- ǻ-35 
DQGǻ-40 constructs demonstrated a SEC profile 
(Fig. 5A) similar to WKDW REWDLQHG IRU WKHǻ-30 
DQG ǻ-40 deletions (Fig. 1). In particular all 
featured the presence of a more-or-less resolved 
peak containing only HSPB6 homodimers.  At the 
same time, the ǻ-25 construct behaved like the 
WT protein (Fig. 5A). As before, the C46S.E116C 
double mutation was introduced into each 
truncation to examine heterodimer formation by 
disulfide cross-linking (Fig. 5B). As expected the 
ǻ-25* construct showed wild type behavior, 
revealing almost exclusively cross-linked 
heterodimers with HSPB1 on a non-reducing SDS-
PAGE. In contrast, the remaining three 5aa 
deletion constructs revealed the presence of both 
homo- and heterodimers, with some specific 
differences between them. In the FDVHRIǻ-30* 
DQG ǻ-35*, densitometry of the various 
disulfide-linked species showed approximately 
20% heterodimer formation. This suggests that 
these two 5aa deletions are severely limited in 
their ability to form hetero-oligomers with 
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HSPB1, similar to the corresponding 10aa 
deletions (Fig. 2B and 5B). At the same time, these 
two smaller deletion constructs fully oxidize on 
their own (Fig. 5& )RU ǻ-40*, the bands 
corresponding to HSPB1 homodimers, 
heterodimers and HSPB6 homodimers had a molar 
ratio of 1:2:1, suggesting a stochastic exchange of 
monomers. For each of the 5aa deletions, the ratios 
of the two homodimers and the heterodimer seen 
on a non-reducing SDS-PAGE could be further 
confirmed by analyzing the cross-linked samples 
using MS under denaturing conditions (Fig. 5E).  
As the disulfide cross-link is chemically 
labile and can exchange with non-oxidised 
species, we confirmed the observed differences 
between the four constructs using the chemical 
cross-linker bismaleimidoethane (BMOE; 
Supplemental Fig. 3). One of the preferred 
configurations of this compound results in the 
maleimide groups being at a suitable distance to 
cross-link the cysteine residues at the dimer 
interface. Incubation of the preheated mixtures 
with BMOE for only 15 mins at 4°C resulted in a 
pattern that was equivalent to that seen by 
disulfide mediated cross-linking (Fig. 5B and 
Supplemental Fig. 3C).  
 The differences between the ǻ-30/ǻ-
35 constructs and the ǻ-40 construct point to a 
possible dual role played by the central part of the 
HSPB6 NTD. Firstly, residues 26 to 35, which 
contain the highly conserved RLFDQxFG motif 
(Fig. 5D), are necessary for facilitating subunit 
exchange. Secondly the residues 36 to 40 appear 
to define the preferential heterodimeric interaction 
between both sHSPs. 
 
Asymmetric roles of equivalent NTD regions in 
HSPB1 and HSPB6 
 
 Since residues 27 to 34 within the NTD of 
HSPB6 are highly conserved in HSPB1 (Fig. 5D), 
we wondered whether homologous deletions in 
HSPB1 would have a similar effect on the 
heterooligomer formation. To this end, we created 
the +63%ǻ-DQG+63%ǻ-35 constructs 
each being an equivalent of the corresponding 5aa 
deletant of HSPB6 (the residue numbering is 
consistent between the two proteins in this region). 
Both HSPB1 truncations readily formed 
heterooligomeric complexes with WT HSPB6 as 
observed by SEC (Fig. 6A and B), while disulfide 
cross-linking experiments revealed that such 
complexes were predominantly built from 
heterodimers (Fig. 6C). These results are in strong 
contrast with the observations for the equivalent 
deletions in HSPB6, which had a negative effect 
on subunit exchange between the two orthologues 
(Fig. 5).  
&XULRXVO\ WKH +63%ǻ-30 construct 
readily formed heterooligomers with HSPB6 at 
4°C, yielding a SEC profile that was only seen for 
the WT sHSP mixture when heated to 37°C (Fig. 
6A). This observation can possibly be attributed to 
an increase in HSPB1 subunit turnover, thereby 
allowing interaction with HSPB6 even at low 
temperatures. ,WVKRXOGEHQRWHGWKDW+63%ǻ-
30 alone forms somewhat smaller oligomers than 
the WT HSPB1, evident from a shift of the SEC 
elution peak during purification (data not shown). 
,Q DGGLWLRQ +63%ǻ-30 does not cross-link 
efficiently with itself (Fig. 6C), a result that 
suggests that residues 26-30 may be important for 
HSPB1 oligomerization, or might somehow affect 
the register of the ACD dimer interface (16). When 
incubated at 37°C, the heterooligomers formed by 
+63%ǻ-30 and HSPB6 showed a major peak 
at 300 kDa, a value that is an intermediate of the 
two peaks usually observed for the WT HSPB1 
and HSPB6 hetero-oligomers (Fig. 6A). In 
comparison, heterooligomerisation of the 
HSPB1.ǻ-35 construct and HSPB6 occurred 
only upon incubation at 37°C, and led to the 
formation of heterooligomeric complexes which 
revealed an asymmetric SEC profile with a single 
maximum at 500 kDa, corresponding to the larger 
heterooligomer species seen when mixing both 
WT proteins (Fig. 6A).  
The results from deletion of the 26-35 
region in HSPB1 suggest there is an asymmetry 
between HSPB1 and HSPB6 in the role of this 
highly conserved sequence for heterooligomer 
formation. To assess whether this depends on the 
small sequence differences in this region between 
the two sHSPs, or is driven in part by their context 
within the respective full-length proteins, two 
domain swaps of this region were created (Fig. 
7A). These 10-residue swaps change the sequence 
GRLFDQRFGE of HSPB6 to SRLFDQAFGL of 
HSPB1 and vice versa, which corresponds to triple 
mutantions indicated in bold. Swapping of these 
residues led to wild type heterooligomerisation 
behavior for HSPB6 containing the HSPB1 
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sequence (HSPB6.10swap) when mixed with WT 
HSPB1. The opposite swap in HSPB1 
(HSPB1.10swap) also yielded heterooligomers, 
but with a preference for forming predominantly 
larger assemblies (Fig. 7B). In both cases, the 
complexes readily oxidized when mixing with the 
appropriate HSPB6* mutant yielding mainly 
heterodimers when analyzed by non-reducing 
SDS-PAGE showing that the mutations did not 
hamper heterodimersation (Fig. 7C).  
An equimolar mixture of the two 10swap 
mutants resulted in a SEC profile similar to that 
seen with the HSPB1.10swap and WT HSPB6 
(Fig. 7B). The asymmetric elution, with a single 
maximum at ~500 kDa, was also observed with 
WKH+63%ǻ-35 construct (Fig. 6B) and points 
to a role of either A32 or L35 of HSPB1 in the 
concentration-dependent formation of  the second 
smaller heterooligomeric species typically 
observed with the mixtures of the WT proteins 
(Fig 7B). The fact that the mixture of the two 
10swap mutants did not result in a wild type SEC 
profile, despite the HSPB6 chimera containing the 
HSPB1 26-35 region, suggests that the mode of 
action of A32 or L35 occurs only when they found 
within the full-length HSPB1 protein.       
To investigate the role of residues 36-40 in 
driving preferential heterodimerization, we also 
swapped this region between the two sHSPs (Fig. 
7A). These swaps correspond to four mutations in 
each construct, exchanging residues GLLEA of 
HSPB6 to PRLPE of HSPB1 (HSPB6.5swap) and 
vice versa (HSPB1.5swap). When mixed with 
HSPB1 the HSPB6.5swap chimera led to only 
stochastic subunit exchange as observed by SEC 
and cross-linking studies using the HSPB6.5swap* 
mutant (Fig. 7B and C). This behavior was 
HTXLYDOHQW WR WKDW VHHQ ZLWK WKH +63%ǻ-40 
deletion construct and points to the role of one or 
more of the mutated residues in heterodimer 
formation. The converse HSPB1.5swap with 
HSPB6 resulted in heterodimer formation, albeit 
yielding heterooligomers of a much higher 
molecular weight than seen with the WT proteins 
(Fig. 7B and C). The fact that the HSPB1.5swap, 
which is effectively HSPB6-like in the 36-40 
region, did not demonstrate stochastic exchange 
with HSPB6 as has been reported for the latter 
sHSP alone (35), suggests that the preferential 
heterodimerization between these two sHSP is not 
driven by these positionally equivalent regions 
interacting with each other in the heterooligomer. 
Combined these results support a model where 
residues 36-40 in HSPB6 likely interact with 
different residues in HSPB1 to drive the formation 
of the heterodimer. The asymmetric behavior of 
this region in both sHSPs was further evaluated by 
mixing the two 5swap constructs together. The 
presence of remnant HSPB6 in the SEC profile 
suggests that residues 36-40 only acts within the 
context of the surrounding NTD residues in 
HSPB6 (Fig. 7B). 
 
Mapping of specific residues involved in 
heterooligomerization 
 
 The slight bias in overall heterooligomer 
size for the HSPB1.10swap was further 
investigated by point mutations. Since most of the 
sequence is similar, we decided to mutate the 
differing residues in the conserved stretch. HSPB6 
has an arginine at position 32 where HSPB1 has an 
alanine (Fig. 5D). A point mutation was created in 
both sHSPs to convert it to the sequence of the 
other and these confirmed the results seen using 
the larger swaps: HSPB1.A32R (B6-like) form 
complexes with HSPB6 that are larger than with 
the WT HSPB1, whereas HSPB6.R32A (B1-like) 
demonstrates a SEC profile that is wild type (Fig. 
8A). When mixing both mutations, the same 
profile was seen as for the HSPB1.A32R-HSPB6 
complex, showing that this arginine is acting 
within the context of HSPB1 and is responsible for 
the larger size oligomers, whereas this residue in 
HSPB6 does not seem to be involved in 
interactions (results not shown). 
 As neither of the 10swap constructs 
PLPLFNHG WKH EHKDYLRU VHHQ IRU WKH ǻ-30 and 
ǻ-35 constructs of HSPB6, point mutations of 
the key conserved residues were also created. It 
has been shown previously that phenylalanines in 
the NTD play an important role in intersubunit 
contacts (37). This region in HSPB1 and HSPB6 
contains two such residues. We therefore 
generated mutants of one (F33A) or both (F29A 
and F33A, termed FFAA) for each sHSP. Different 
permutations of these mutants, mixed with either 
the WT or mutant partner, were examined. Mixing 
HSPB6.F33A with WT HSPB1 led to a 
chromatogram similar to that obtained for 
+63%ǻ-35 (Fig. 8A), suggesting that this 
phenylalanine residue in HSPB6 is important in 
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heterooligomer formation, a result confirmed by 
disulfide cross-linking using the HSPB6.F33A* 
mutant (Fig. 8B). However, the opposite 
experiment, mixing WT HSPB6 with 
HSPB1.F33A, did not hamper the preferred 
heterodimerisation of these two sHSPs as 
evaluated by the oxidation experiment (Fig. 8B). 
Unexpectedly though, the HSPB1.F33A mutation 
led to exchange of subunits at 4°C, as evidenced 
by a reduction of the HSPB6 peak, and the 
formation of smaller heterooligomeric species 
(~300 kDa) following heating. This behavior was 
similar to that observed with the HSPB1.ǻ26-30 
deletion mutant (Figs. 8A and 6A). As seen before, 
this suggests an asymmetric role for this highly 
conserved residue in defining the interaction 
between these two sHSPs. 
 When mixing the HSPB1.F33A and 
HSPB6.F33A, together a unique chromatogram 
was observed (Fig. 8A). The broad profile at 4°C 
showed two peaks overlapping, suggesting some 
mixing of the two mutants at low temperature. 
After incubation at 37°C, a shift in the ratio of the 
peak maximas could be noticed but the overall 
shape of the elution profile remained similar to the 
unheated sample. Disulfide cross-linking showed a 
minor fraction of heterodimers as similar to that 
seen for the mixture of WT HSPB1 and 
HSPB6.F33A* (Fig. 8B). Combined, the data 
suggests that these mutants can associate at lower 
temperatures but subunit exchange is severely 
hampered. 
 The results for the double mutations 
(FFAA) looked exactly like those for the single 
phenylalanine substitutions, alluding to a more 
important role for F33 than F29 in both proteins 
(Fig. 8A). It should be noted that the mutations in 
HSPB1 yielded smaller homooligomers than the 
WT protein as assessed by SEC during purification 
(results not shown), and that the FFAA construct 
did not cross-link to the same extent as the WT 
protein on its own (Fig. 8C). This suggests an 
important role for the phenylalanine residues in 
HSPB1 homooligomerization. These phenyl-
alanines thus seem essential to allow the 
interaction between HSPB1 and HSPB6 and are 
involved in important intersubunit contacts in the 
oligomeric assemblies. 
 
DISCUSSION 
 
 Heterooligomerization of sHSPs has long 
been recognized in different organisms, although 
the exact function and benefit of such assemblies 
is still unknown. As many members of the family 
tend to form such mixed oligomers, information 
about their structure and the determinants of the 
assembly process should help to understand the 
chaperone activity of sHSPs and their interaction 
with different partner proteins. We have focused 
our attention on HSPB1 and HSPB6, two human 
sHSPs that are highly expressed in muscle tissue 
(33). 
 Previously it has been shown that HSPB1 
and HSPB6 preferentially form heterooligomers 
over interactions with other orthologues (21). This 
is most likely the result of their propensity to yield 
species composed solely of heterodimers when 
mixed together (35), suggesting a biased 
association at the level considered to be the basic 
building block of the larger oligomeric assemblies. 
Surprisingly, deletion constructs of the two 
proteins corresponding to the ACD - the only 
structured region that form the core dimer 
interface (15±17) - were found to 
heterooligomerize in a stochastic fashion (35). It is 
the NTD, a region shown to be largely 
unstructured in HSPB6 and predicted to have 
similar properties in HSPB1 (18), that is essential 
for this preferred association. Employing a 
comprehensive set of deletion mutants of HSPB6 
we have identified three regions of importance 
within its NTD that affect the heterooligomer 
assembly with HSPB1 (Table 2). 
Firstly, we have discovered that a 
conserved motif P(G/F/Y)Y, which is located at 
position 52-54 in the second half of the NTD of 
HSPB6 and found at an equivalent position in a 
number of other orthologues known to interact 
with this sHSP (Fig. 4B), seems to regulate the 
size of the resultant heterooligomer. Deletion of 
these residues in HSPB6 leads to the formation of 
smaller heterooligomeric species with HSPB1, 
albeit composed of the canonical heterodimers 
(Fig. 9). Predictions suggest that this region in 
both proteins, like the majority of the NTD, 
contain no secondary structural elements 
(Supplemental Fig. 4). This is in good agreement 
with a recent X-ray crystallographic structure of 
the full-length HSPB6 bound to a 14-3-3 adapter 
protein which showed  that this part of the NTD is 
highly disordered (38). However, studies of 
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HSPB5 oligomers, using solid-state NMR, report 
that the homologous region in this sHSP shows 
chemical shifts UHVHPEOLQJ D ȕ-strand (39). 
Therefore it is possible that in the higher-order 
assemblies formed between HSPB1 and HSPB6 
some structure is induced that is necessary for 
association. Indeed the importance of this region 
in HSPB5 has been highlighted by pin array 
experiments, where peptides encompassing this 
sequence were identified to interact with HSPB4 
(40), suggesting a possible conserved role in 
hetero-association. 
Secondly, we have found that the highly 
conserved RLFDQxFG sequence (36), is a 
prerequisite of heterooligomerization. Intriguingly 
this motif is always present in sHSPs reported to 
form heterooligomers with HSPB6 (Fig. 5D), but 
is absent in a number of homologues, including 
HSPB3 (Supplemental Fig, 4C), an sHSP that has 
been shown not to interact with HSPB6 (20).  This 
predicted unstructured sequence (Fig. 5D) appears 
to be necessary for the exchange of HSPB6 
subunits with HSPB1. This region was previously 
identified as a negative regulator of activity in 
HSPB6 and was also found to control both size 
DQGDFWLYLW\LQĮ%-crystallin (36, 41). Specifically 
our results point to the highly conserved 
phenylalanines F29 and F33 as essential for the 
HSPB1/HSPB6 association. Despite their 
conservation between the two sHSPs, there 
appears to be an asymmetry in their importance. 
Just like the deletion of residues 31-35, mutation 
of F33 in HSPB6 effectively blocked hetero-
association, whereas mutation of the equivalent 
residue in HSPB1 led to the formation of smaller 
oligomers but still composed of heterodimers. The 
involvement of phenylalanines of the NTD in 
controlling sHSP association and size has also 
been observed in the fission yeast SpHSP16.0 
where the mutation of F6 or F7 led to an 
impairment of oligomer formation (37). The 
residue bias of phenylalanines in the NTD in 
genome-wide studies suggests this is likely a 
common phenomenon (42). 
Thirdly, we have identified a region in the 
NTD of HSPB6, with no functional equivalent in 
HSPB1, which is responsible for the preferential 
heterodimerization of these two sHSPs. 
Specifically deletion or mutation of residues 36-40 
of HSPB6 resulted in a protein that could form 
heterooligomers with HSPB1, but contained 
HSPB1 and HSPB6 homodimers alongside the 
heterodimers. Importantly the observed molar ratio 
of the three species suggest a stochastic exchange 
of subunits at the monomer level. The same 
behavior was seen for the heterooligomerization of 
HSPB1 and HSPB6 truncations each missing the 
whole NTD (35). Since swapping of this sequence 
into HSPB1 had no observable effect on subunit 
exchange, that is that the HSPB1.5swap chimera 
did not show a preferred association with itself 
over HSPB6, we conclude that these residues 
function within the context of the heterodimer. 
Thus the 36-40 region is somehow responsible for 
stabilizing the interface of the ACDs occurring 
within a heterodimer. The aforementionedstructure 
of HSPB6 in complex with a 14-3-3 adapter 
protein has shown that regions of the NTD can 
thread through the shared groove formed between 
WKHȕ-strands of the ACD dimer (38). Patching of 
this same groove in the heterodimer, by one of 
more residues in the 36-40 region of HSPB6, 
could possibly stabilize this new interface and 
explain the asymmetric behavior of this 
interaction.   
A recent study of heterooligomer 
formation between HSPB5 and HSPB6 has 
proposed a model in which the C-terminal IxI/V-
motif of HSPB5 is required for the initial capture 
of the HSPB6 dimer, whereupon a new 
heterodimer interface is formed and stabilized by 
the NTD of HSPB6 (43). Assuming a similar 
model of association between HSPB1 and HSPB6 
the results presented here can extend our 
understanding of this association further (Fig. 9). 
Initially, HSPB6 is recruited to the HSPB1 
homooligomer via the interaction of its ACD with 
the C-terminal IxI/V-motif of HSPB1. Although an 
equivalent C-terminal localized motif is missing in 
HSPB6, its ACD has been shown to readily bind 
sequences containing this tripeptide sequence (18, 
38, 43, 44). Following this capture step 
incorporation of HSPB6 into the HSPB1 oligomer 
is dependent, firstly, on the formation of 
HSPB1/HSPB6 heterodimers. Indeed, Mymrikov 
et al. (21) have shown that heterooligomerization 
is blocked by disulfide cross-linking of both 
sHSPs prior to mixing. Therefore stable 
incorporation of HSPB6 is dependent on localized 
dissociation of both the HSPB1 and HSPB6  
homodimers and subunit exchange, in agreement 
with the earlier model (43).  Secondly our data 
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shows the conserved NTD motif, and in particular 
residue F33, plays an important role in this initial 
subunit exchange. In the case of HSPB1, mutation 
of this residue to alanine enhances the recruitment 
of HSPB6, while the equivalent mutation in 
HSPB6 severely hampers this process. This 
suggests that the conserved motif of HSPB6 must 
displace an interaction made by the same sequence 
in the HSPB1 homooligomers to permit 
homodimer dissociation and subunit exchange 
(Fig. 9). Finally, our experiments show that, 
uniquely for the HSPB1 and HSPB6 mixed 
complex, residues 36-40 of the latter sHSP 
enhances preferential hetero-association at the 
ACD interface in the heterooligomers. Whether 
this HSPB6 mediated biased association already 
occurs during initial subunit incorporation, or 
appears as a result of the free exchange of subunits 
in the heterooligomeric species as presented in 
Fig. 9, cannot be ascertained from the equilibrium 
experiments performed here.  
The involvement of the NTD in defining 
the strength and specificity of the newly formed 
ACD dimer interface is quite remarkable. Indeed, 
we have found this intrinsically disordered region 
to be highly implicated in dictating the properties 
of the sole structured region in these proteins. 
Similar involvement of the NTD and CTD have 
been published for HSPB5, where binding of the 
CTD destabilizes the dimer interface (45), and 
phosphorylation of N-terminal serine residues 
leads to loss of dimeric substructure in the 
homooligomers (46). In summary, modifications 
such as phosphorylation within the NTD may have 
a profound effect on the structure of sHSPs and 
can even lead to a destabilization of the ACD 
dimer interface, suggesting that indeed this region 
must interact with the ACD core and function 
either as a stabilizer or destabilizer, dependent on 
the modifications present. 
 Many reviews have acknowledged the 
potential of sHSPs both as drug targets and for 
biotechnological applications (47±51). To create 
inhibitors or enhancers of sHSP activity, a detailed 
understanding of their function and the sequences 
involved is necessary. Similarly, to use sHSPs as 
nanomaterials for activities such as targeted drug 
delivery or imaging purposes, it is crucial that we 
understand the sequence properties that define the 
size and shape of these oligomers. Studies 
focusing on sHSP heterooligomerization could 
bring us one step closer to eventually designing 
sHSPs with tailored properties. 
This work is the first to fully explore the 
sequence properties in defining hetero-
oligomerization of two human sHSPs. The results 
described here show a complicated yet important 
interplay between the NTD, which features a high 
degree of intrinsic disorder, and the structured 
ACD, in regulating size and stability of the 
complexes, proving that the terminal regions in 
sHSPs play an important role in defining their 
assembly properties. As these same regions also 
have a role in chaperone activity (35, 36), a 
correlation between the ability to 
heterooligomerize and to protect substrates from 
aggregating should be logically expected. A 
systematic investigation of this interplay, which is 
clearly relevant in vivo, is necessary. 
 
EXPERIMENTAL PROCEDURES 
 
 Mutagenesis and cloning - The previously 
described small ubiquitin modifier (SUMO)-
fusions of HSPB1 and HSPB6 (16) were used as a 
template for the generation of additional deletion 
constructs and point mutations. Point mutations 
were created using site-directed mutagenesis. 
DpnI-treated PCR products were transformed into 
E. coli 1(%Į 1HZ (QJODQG %LRODEV DQG
positive clones were verified by sequencing. A 
double mutant C46S.E116C of HSPB6, in which 
the native cysteine-46 is mutated to serine, and 
glutamate-116 at the dyad axis of the ACD dimer 
is mutated to cysteine, was created using two 
rounds of mutagenic PCR. This mutant was also 
used as a template to create additional N-terminal 
deletions using a PCR-based overlap mutagenesis 
method described previously (36). A similar 
approach was employed to generate the HSPB1 
and HSPB6 sequence swaps. All constructs were 
designed such that, upon cleavage of the linearly 
fused SUMO chimera with recombinant SUMO-
hydrolase, no additional non-native residues were 
present on the target protein (52). 
Expression and purification - All 
constructs were transformed into the E. coli 
Rosetta 2 (DE3) pLysS strain (Novagen) and 
clones were cultured in ZYP-5052 auto-inducing 
medium (53) using described conditions (16). Cell 
were harvested by centrifugation at 8000 x g, 
resuspended in buffer (50 mM sodium phosphate, 
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250 mM sodium chloride and 12.5 mM imidazole, 
pH7.5) and stored at -80°C. For the expression of 
15N-labeled proteins, transformed clones were 
cultured in 2 mL of LB medium for 7h. This 
culture was then transferred to 50 mL of P0.5G-
medium (53) and grown overnight at 25°C. 10 mL 
of this culture was spun down at 3000 rcf and the 
pellet was transferred to 200 mL of auto-inducing 
minimal medium containing 15N-ammonium 
chloride (53). Cells were grown and harvested 
using the same conditions as above. 
Cells were thawed and diluted in the same 
buffer complemented with 1 unit/mL of Cryonase 
Cold Active Nuclease (Clontech) and 10 mM 
MgCl2. Cells were lysed by sonication in 3 cycles 
with 20 minutes in between each cycle. Further 
purification by IMAC, ion exchange and size 
exclusion was performed as described previously 
(36, 52). 15N-labeled proteins were purified using 
the same protocol except the final SEC was 
performed using a Superdex 200 10/300 GL 
column pre-equilibrated in 200 mM ammonium 
acetate pH6.9 containing 2.5 mM DTT. 
Analytical size-exclusion chromatography 
- Prior to analysis, 220 µM (corresponding to 5 
mg/ml for HSPB1) of each protein was mixed in 
20 mM HEPES pH 7.4, 150 mM NaCl and 10mM 
DTT to produce hetero-oligomeric complexes. The 
mix was incubated overnight at 37°C to allow 
complete subunit exchange. 100 µL of each 
protein or complex was loaded onto a Superdex 
200 10/300 GL column (GE Healthcare Life 
Sciences), pre-equilibrated at 4°C in 20 mM 
HEPES pH 7.2, 150 mM NaCl and 2.5 mM DTT 
using a flow-rate of 0.5 mL/min. The column was 
calibrated using standards from the Molecular 
Weight Calibration kit (GE Healthcare Life 
Sciences) including blue dextran, ferritin, aldolase, 
conalbumin, ovalbumin, carbonic anhydrase, 
ribonuclease A and aprotinin. The standards were 
diluted in the same buffer and run under the same 
conditions. 
 Disulfide cross-linking - For oxidation 
cross-linking experiments, 50 µM of each protein 
was mixed in 50 mM sodium phosphate pH 7.5, 
100 mM NaCl and 5 mM DTT, incubated 
overnight at 37°C, and then subjected to dialysis 
for 48 hr at  20°C  with the same buffer without 
DTT. 10 µL from this mixture was analyzed on a 
non-reducing SDS-PAGE containing 15% 
acrylamide. Reduced controls were obtained by 
diluting the samples with buffer with DTT before 
loading. Densitometry using ImageJ of  the 
Coomassie-stained gels was used to quantify the 
molar amounts of protein present in each band, 
whereby the reference bands containing the known 
molar amounts of fully oxidized HSPB6*, HSPB1 
or the HSPB6*/HSPB1 heterodimers were used 
for calibration. 
 Chemical cross-linking ± The purified 
proteins were dilaysed against 50 mM  sodium 
phosphate, 100 mM NaCl, 1 mM EDTA, and 2 
mM Tris(2-carboxyethyl)phosphine (TCEP), pH 
7.5 at 4°C. The buffer was exchanged three times 
to ensure the complete removal of DTT. A solution 
containing 50 µM of each construct (i.e. 100 µM 
total sHSP for the 1:1 mixtures of HSPB1 and 
each HSPB6* mutant) was prepared and heated at 
42°C for 1.5 hr. TCEP was then removed from 
each reaction using a Zeba spin desalting column 
with a 40 kDa molecular weight cutoff 
(ThermoFisher Scientific) pre-equilibrated with 50 
mM sodium phosphate, 100 mM NaCl, 1 mM 
EDTA pH 7.5. The samples, containing no 
reducing agent, were split in half and placed at 
4°C. To one tube a 1.1 molar excess of 
bismaleimidoethane (BMOE), solubilized in 
DMSO, was added. Following a 15 min incubation 
period 10 µL of each reaction was taken and cross-
linking stopped by the addition of SDS-PAGE 
loading buffer containing 100 mM ȕ-
mercaptoethanol. The second tube, containing no 
cross-linker, was incubated for 1 hr at 4°C.  At this 
point a 10 µL sample was taken and diluted in 
SDS-PAGE sample buffer containing no reducing 
agent. All samples were analyzed by SDS-PAGE 
using a 12-15% acrylamide gradient. 
Mass spectrometry - All MS 
measurements were performed on a 
quadrupole/ion mobility/time-of-flight instrument 
with ion mobility capabilities (Synapt G2 HDMS, 
Waters, Wilmslow, UK), operated in positive ion 
mode. Data acquisition and processing were 
performed using MassLynx (version 4.1) and 
external calibration up to 5000 m/z was performed 
with CsI solution.  
For native MS analyses of the complexes, 
200 µM (monomer concentration) of each protein 
was mixed together in 200 mM ammonium acetate 
pH 6.9, 2.5 mM DTT and incubated overnight at 
37°C. The samples were further dialyzed against 
the same buffer in three exchanges, over a 24 hr 
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period, to ensure complete removal of nonvolatile 
salt. Approximately 5 µL of solution containing 20 
µM of protein (monomer concentration) diluted 
with the 200 mM ammonium acetate pH 6.9, 2.5 
mM DTT buffer was transferred to gold-coated 
glass capillaries prepared in-house and infused 
into the mass spectrometer using the nanoflow 
version of the Z-spray ion source. A capillary 
voltage of 1.0 ± 1.3 kV and minimal (<0.2 bar) 
nanoflow gas pressure were used, and the 
instrument was operated in Mobility/Sensitivity 
mode. Instrument parameters were as follows 
unless stated otherwise: sample cone 80 V, 
extraction cone 1 V, backing pressure 3.2 ± 4.5 
mbar, source pressure 4.6e-3 ± 5.8e-3 mbar, trap 
collision energy 10 V, trap DC bias 50 V, transfer 
collision energy 5 V. The IM cell was filled with 
3.5 mbar of N2 (He cell gas flow 180 mL/min, 
IMS gas flow 60 mL/min), and IM wave height 
and velocity were 40 V and 1000 m/s, respectively. 
 MS analyses of cross-linked species were 
performed in the denatured state on the same 
instrument, but in this case the protein 
concentration was reduced to 2 µM (monomer 
concentration) in 50 % acetonitrile and 1% formic 
acid. The instrument was operated in 
TOF/Sensitivity mode for these experiments, with 
the following settings: capillary voltage 1.0 kV, 
sampling cone 40 V, extraction cone 2 V, backing 
pressure 2.5 mbar, source pressure 4.1e-3 mbar, 
trap collision energy 4 V, trap DC bias 5 V, 
transfer collision energy 0 V. Spectra were 
subsequently deconvoluted using the MaxEnt 1 
module of the MassLynx software to determine 
relative abundances. 
Small-angle X-ray scattering - The 
measurements were performed at Synchrotron 
Soleil (Saint-Aubin, France) as described 
previously (36). 80 µL sample containing 5 mg/ml 
HSPB1 (equivalent to approximately 220 µM) and 
the molar equivalent of HSPB6, incubated at 45°C 
for 1 h to form complexes, which has been shown 
to be sufficient for complex formation (31), was 
loaded onto a Shodex KW-404F column at 0.2 
ml/min pre-equilibrated with 50 mM sodium 
phosphate pH 7.5, 100 mM NaCl and 2.5 mM 
DTT. During each run, 100 frames were recorded 
prior to the start of the protein elution towards 
evaluating the buffer scattering. Thereafter 250 
frames were recorded while the complex eluted 
from the column. The exposure time per frame 
was 750 ms, with a dead time of 1500 ms between 
frames. Data processing was done as described 
previously (35). 
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FOOTNOTES  
 
The abbreviations used are: ACD, Į-crystallin domain; CTD, C-terminal domain; MS, mass spectrometry; 
NTD, N-terminal domain; SAXS, small-angle X-ray scattering; SEC, size exclusion chromatography; 
sHSP, small heat shock protein.  
 
FIGURE LEGENDS 
 
FIGURE 1. Role of the NTD of HSPB6 in heterooligomerization. Analytical SEC profiles of 
equimolar mixtures of HSPB1 and each HSPB6 deletion following overnight incubation at 37°C.  A 100 
µl sample was loaded onto a Superdex 200 10/300  column equilibrated in 20 mM HEPES, 150 mM NaCl 
and 2.5 mM DTT. The chromatogram of the control sample (the equimolar mixture stored at 4°C) is 
shown as a grey filled curve, the heated mixture is shown as a black curve. Fractions (F) are denoted at 
the base of each curve, their identities are shown on the bottom left panel.  Right-hand side, 
corresponding SDS-PAGE analysis of the fractions from analytical SEC. An input sample (i) of the 
equimolar mix of both sHSPS taken prior to injection onto the column, and the same sample diluted 10-
fold (i/10) were also loaded. 
 
FIGURE 2. Disulfide cross-linking studies of HSBP1/HSPB6* heterocomplexes. (A) Cartoon 
representation of the putative ACD heterodimer interface. Residues E116 of HSPB6 (green ribbons) and 
C146 of HSPB1 (cyan ribbons) are shown in red as all-atom representations. (B) Reducing SDS-PAGE 
analysis of HSPB1 and HSPB6 C46S.E116C (HSPB6*) constructs. (C) Non-reducing SDS-PAGE 
analysis of the complexes between HSPB1 and the seven different HSPB6* deletion constructs. Samples 
were incubated at 37°C overnight in 50 mM sodium phosphate pH 7.5, 100 mM NaCl and 5 mM DTT 
and then dialyzed against the same buffer without DTT to permit disulfide cross-linking. (D) Control 
experiment showing the non-reducing SDS-PAGE analysis of each HSPB6* deletion construct following 
extensive dialysis to remove DTT. 
 
FIGURE 3. Native mass spectrometry analysis of mixtures of HSPB1 and the HSPB6 deletions. 
Native MS of the HSPB1-HSPB6 deletion complexes, 20 µM (monomer concentration) of each 
preincubated mixture in 200 mM ammonium acetate pH6.9 containing 2.5mM DTT was analyzed on a 
Synapt G2 HDMS (Waters). Charge states are indicated above each peak. 
 
FIGURE 4. Iterative mapping of the region containing residues 51 to 60. (A) Analytical SEC profile 
of an equimolar mixture of HSPB1 and the HSPB6 ǻ51-55 and ǻ 56-50 truncations following overnight 
incubation at 37°C. The SEC profile of the control sample (mixture stored at 4°C) is shown as a black 
dashed line, the heterooligomer (incubated at 37°C) is shown as a continuous black line. For each 
chromatogram the profile of the heterooligomer for WT HSPB1 and HSPB6 is shown as a red dashed 
line. (B) Alignment of the 50-60 region of HSPB6 with equivalent sequences from human homologues 
reported to interact with this sHSP. Residues are highlighted using the Clustal color scheme. The 
numbering above the alignment corresponds to the residue position in human HSPB6.  Uniprot accession 
numbers: HSPB6, O14558; HSPB1, P04792 ; HSPB2, Q16082;  HSPB5, P02511; HSPB8; Q9UJY1. 
 
FIGURE 5. Iterative mapping of residues 21 to 40 containing the conserved region. (A) Analytical 
SEC profiles of an equimolar mixture of HSPB1 with either HSPB6 ǻ-ǻ-ǻ-35 RUǻ-40 
following overnight incubation at 37°C. The control sample (kept at 4°C) is shown with black dashed 
line, the hetero-oligomer (incubated at 37°C) is shown as a black line. For each chromatogram the hetero-
oligomer for WT HSPB1 and HSPB6 is shown as a red dashed line. (B) Non-reducing SDS-PAGE 
analysis of the disulfide cross-linked complexes between HSPB1 and the four HSPB6* truncations. (C) 
Control experiment showing the non-reducing SDS-PAGE analysis of all oxidized constructs on their 
own. (D) Sequence alignment, and corresponding consensus secondary structure (CSS) predictions of the 
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21-40 region of HSPB6 and known interacting homologues. Aligned residues are shaded using the Clustal 
colour scheme. The numbering above the alignment corresponds to the residue position in human HSPB6. 
The database identity of each sequence is presented in the legend to Fig. 4. The CSS for each sequence 
was determined using the GeneSilico meta-server (54). (E) MaxEnt 1 deconvoluted mass spectra of 
oxidized samples.  
 
FIGURE 6. Deletion of the conserved region in HSPB1. (A) Analytical SEC profiles of an equimolar 
mixture of HSPB1 ǻ-RUǻ-35 deletion constructs and WT HSPB6 following overnight incubation 
at 37°C. The control sample (sample kept at 4°C) is shown with black dashed lines, the hetero-oligomer 
(incubated at 37°C) is shown as a black line. For each chromatogram the hetero-oligomer for WT HSPB1 
and HSPB6 is shown as a red dashed line. (B) Non-reducing SDS-PAGE analysis of the complexes 
between the HSPB1 deletions and HSPB6*.  (C) Control experiment showing the non-reducing SDS-
PAGE analysis of HSPB1 ǻ-RUǻ-35 following extensive dialysis to remove DTT. 
 
FIGURE 7. Domain swapping of conserved region in HSPB1 and HSPB6. (A) Cartoon representation 
of the constructs used. The figures were created using DOG (55). (B) Analytical SEC profiles of an 
equimolar mixture of the various HSPB1 and HSPB6 swaps following overnight incubation at 37°C. The 
control sample (stored at 4°C) is shown as a black dashed line, the hetero-oligomer (incubated at 37°C) is 
shown as a continuous black line. For each chromatogram the hetero-oligomer for WT HSPB1 and 
HSPB6 is shown as a red dashed line. (C) Non-reducing SDS-PAGE analysis of the complexes between 
the HSPB1 and HSPB6* swaps. (C) Control experiment showing the non-reducing SDS-PAGE analysis 
of different constructs following extensive dialysis to remove DTT  
 
FIGURE 8. Point mutation analysis of the conserved region in HSPB1 and HSPB6. (A) Analytical 
SEC profile of an equimolar mixture of various HSPB1 and HSPB6 point mutations following overnight 
incubation at 37°C. The control sample (stored at 4°C) is shown as a black dashed line, the hetero-
oligomer (incubated at 37°C) is shown as continuous black line. For each chromatogram the hetero-
oligomer for WT HSPB1 and HSPB6 is shown as a red dashed line. (B) Non-reducing SDS-PAGE 
analysis of the complex between HSPB1 and HSPB6* point mutants (C) Control experiment showing the 
non-reducing SDS-PAGE analysis of different constructs following extensive dialysis to remove DTT.  
 
FIGURE 9. Cartoon summarizing the regions of HSPB6 involved in heterooligomer formation. (1) 
The CTD of HSPB1 recruits HSPB6 via patching of the hydrophobic groove formed between the ȕDQG
ȕ-strands of the ACD (represented by semi-circle) of the latter sHSP. This interaction is blocked by 
mutation of S134 in HSPB6 and by disulfide cross-linking (S-S) of both proteins  (21, 43). (2) Residue 
F33 of the NTD of HSPB6 destabilises the NTD interactions in the HSPB1 homooligomer permitting 
subunit exchange and full incorporation of HSPB6. (3) Within the resultant heterocomplex the individual 
subunits can freely exchange, (4) preferential heterodimerisation within the mixed oligomer is driven by 
residues 36-40 of HSPB6. (5) The heterooligomer is found in an equilibrium of two species, the 
populations of which are regulated by residues 51-55 in HSPB6.     
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TABLE 1. SAXS analysis of the hetero-oligomeric complexes of HSPB1 and HSPB6 deletion 
constructs. The SAXS frames were processed using AUTORG (56) and GNOM (56, 57). The second last 
column shows the Rg value at the elution peak. The last column shows the Rg range corresponding to the 
frames for which the quality measure in AUTORG was 50 % or higher.  
 
Protein 
Estimated average MW 
(kDa) based on Porod 
volume 
Calculated 
average number 
of subunits 
Peak 
Rg (Å) Rg range  
B1.WT 647.6 28.4 58.2 63.0 ± 56.0 
B6.WT 45.9 2.7 32.4 32.9 ± 27.5  
B1 + B6 342.4 17.2 51.1 52.4 ± 39.5  
%%ǻ1 311.7 16.1 49.6 50.9 ± 39.7  
%%ǻ-20 212.1 10.9 48.0 51.1 ± 35.2  
%%ǻ-30 490.8 25.2 56.9 57.1 ± 31.5  
%%ǻ-40 478.9 24.7 57.0 57.3 ± 33.2  
%%ǻ-50 356.4 18.3 52.2 52.9 ± 44.9  
%%ǻ-60 134.7 6.9 41.6 48.2 ± 33.7  
%%ǻ-70 337.6 17.3 51.2 51.8 ± 42.5  
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Table 2. Summary of the heterooligomerisation properties of HSPB6 deletions and point 
mutations with HSPB1. 
 
10 amino acid deletions 5 amino acid deletions Point mutations 
Construct SEC
a
 S-S
b
 Construct SEC
a
 S-S
b
 Construct
c
 SEC
a
 S-S
b
 
ȴN11 WT 1 ȴ21-25 WT 1 10swap WT 1 
ȴ11-20 WT 1 ȴ26-30 Remnant 
HSPB6 
1:0.5:1 5swap 
Remnant 
HSPB6 
1:0.5:1 
ȴ21-30 Remnant 
HSPB6 
1:0.5:1 ȴ31-35 Remnant 
HSPB6 
1:0.5:1 R32A WT 1 
ȴ31-40 Remnant 
HSPB6 
1:0.5:1 ȴ36-40 Remnant  
HSPB6 
1:2:1 F33A 
Remnant 
HSPB6 
1:0.5:1 
ȴ41-50 WT 1 ȴ51-55 Small 1 FFAA Remnant 
HSPB6 
1:0.5:1 
ȴ51-60 Small 1 ȴ56-60 WT 1    
ȴ61-70 WT 1       
a 
SEC profile of each HSPB6 construct  when mixed in equimolar amounts with HSPB1 and heated.  ?td ? ?
closely resembling the mixture of WT HSPB6 and HSPB1.  ?Remnant HSPB6 ? ?chromatograms contain an 
additional late eluting peak corresponding to the HSPB6 dimer position.  ?Small ? ? chromatograms show a 
profile biased to an approximately 140kDa species. 
b
 Ratio of disulfide crosslinked HSPB1 homodimer, HSPB1 and HSPB6 construct heterodimer, and HSPB6 
construct homodimer as evaluated by non-reducing SDS-PAGE. A single value corresponds to 
heterodimers only. 
C
 10swap corresponds to the HSPB6 G26S\R32A\E35L mutant. The 5swap corresponds to the HSPB6 
G36P\RL37R\E39P\A40E mutant. FFAA corresponds to the HSPB6 F29A\F33A mutant.  
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Figure 1 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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